Page 60 - Retail Pharmacy November/Decemeber 2020

ANNUAL REPORT 59 Top 5 Molecules by Value SOFOSBUVIR + VELPATASVIR GLECAPREVIR + PIBRENTASVIR CEFALEXIN AMOXICILLIN AMOXICILLIN + CLAVULANIC ACID Top molecule growth YoY SOFOSBUVIR + VELPATASVIR GLECAPREVIR + PIBRENTASVIR CEFALEXIN AMOXICILLIN AMOXICILLIN + CLAVULANIC ACID Ranked by value of change BICTEGRAVIR + EMTRICITABINE + TENOFOVIR ALAFENAMIDE VACCINE, INFLUENZA VALACICLOVIR POSACONAZOLE DOLUTEGRAVIR + RILPIVIRINE Top 5 corporate % shares GILEAD SCIENCES ABBVIE MYLAN AUSTRALIA APOTEX VIIV HEALTHCARE MUSCULO-SKELETAL SYSTEM Value ($) $124,049,193 $85,006,855 $70,790,075 $55,462,176 $52,827,425 Value Change (%) -46% -25% -9% -34% -29% Value Change (%) 190% 145% 12% 7% 65% Value ($) $228,235,843 $85,306,387 $62,386,749 $33,976,512 $28,556,370 Volume (units) 9,869 4,537 5,633,804 4,496,879 3,985,975 Volume change (%) -35% -25% -9% -33% -28% Volume change (%) 188% -14% 14% 9% 66% Volume (units) 167,492 8,608 12,055,620 6,222,399 37,308 Top 5 corporate % shares NOVARTIS MUNDIPHARMA JANSSEN CILAG APOTEX MYLAN AUSTRALIA RESPIRATORY SYSTEM Value ($) $162,182,309 $119,789,432 $119,605,434 $100,206,900 $92,928,056 Volume (units) 1,288,339 5,488,651 1,544,599 17,509,288 20,256,305 Value of change ($) -$57,565,760 -$21,227,648 -$6,489,335 -$19,085,765 -$15,187,768 Value of change ($) $22,550,441 $18,612,168 $2,446,983 $1,214,286 $873,298 Pharmacy Volume Volume Change Value of change ($) $26,762,682 -$3,118,765 $20,703,279 $6,022,639 -$656,741 Value of change ($) $26,762,682 $20,703,279 $6,022,639 $4,738,092 $1,404,795 Pharmacy Volume Volume Change Value of change ($) -$7,185,730 -$21,106,690 $1,221,780 -$3,582,238 $8,272,792 Value of change ($) $27,876,799 $11,315,540 $10,997,306 $10,825,257 $10,008,714 Pharmacy Value Value Change Top 5 Molecules by Value SALBUTAMOL $947,184,750 10% Pharmacy Volume Volume Change Value of change ($) $9,692,041 $11,548,806 $15,852,618 -$14,624,916 $8,038,535 Value of change ($) $16,590,366 $15,852,618 $14,553,337 $11,548,806 $11,360,920 Pharmacy Volume Volume Change Value of change ($) $32,049,845 $5,429,422 $385,431 -$3,566,898 -$1,352,635 Value of change ($) $32,049,845 $5,429,422 $989,377 $673,072 $629,684 32,717,140 1% Pharmacy Value Value Change Top 5 Molecules by Value DENOSUMAB DICLOFENAC BARICITINIB TOCILIZUMAB MELOXICAM Top molecule growth YoY DENOSUMAB DICLOFENAC BARICITINIB TOCILIZUMAB MELOXICAM Ranked by value of change DENOSUMAB BARICITINIB TOCILIZUMAB UPADACITINIB HYDROXYCHLOROQUINE Top 5 corporate % shares $583,178,264 9% 15,334,470 FLUTICASONE + SALMETEROL BUDESONIDE + FORMOTEROL TIOTROPIUM BROMIDE FLUTICASONE FUROATE + VILANTEROL Top molecule growth YoY SALBUTAMOL FLUTICASONE + SALMETEROL BUDESONIDE + FORMOTEROL TIOTROPIUM BROMIDE FLUTICASONE FUROATE + VILANTEROL Ranked by value of change FLUTICASONE FUROATE + UMECLIDINIUM BROMIDE + VILANTEROL BUDESONIDE + FORMOTEROL BENRALIZUMAB FLUTICASONE + SALMETEROL OMALIZUMAB Value ($) $137,542,964 $126,389,225 $109,455,321 $63,904,235 $48,515,132 Value Change (%) 7% 9% 14% -23% 17% Value Change (%) 66% 17% 110% 10% 51% Value ($) $245,270,329 $106,323,384 $94,149,413 $33,727,128 $33,428,416 Volume (units) 14,250,926 2,364,688 2,586,237 1,481,941 743,534 Volume change (%) 5% 3% 16% -1% 16% Volume change (%) 70% 20% 108% 3% 50% Volume (units) 5,239,617 2,049,240 2,856,129 838,672 81,373 -1% $248,541,209 $45,096,775 $42,844,525 $39,089,254 $34,905,905 Value Change (%) 11% -7% 48% 15% -2% Value Change (%) 12% 94% 18% NA 20% Value ($) $234,443,777 $41,011,272 $40,736,345 $28,056,570 $14,973,838 Value ($) Volume (units) 878,445 3,535,440 33,621 100,083 2,481,289 Volume change (%) 10% -7% 48% 32% 0% Volume change (%) 12% 93% 46% NA 19% Volume (units) 878,445 33,621 576,784 106,219 594,716 Top 5 corporate % shares GLAXOSMITHKLINE BOEHRINGER INGELHM ASTRAZENECA CIPLA NOVARTIS SENSORY ORGANS Pharmacy Value Value Change Top 5 Molecules by Value AFLIBERCEPT RANIBIZUMAB LATANOPROST $781,340,580 5% 10,443,988 -5% $372,427,113 $202,233,699 $22,113,293 $13,772,222 $13,193,463 Value Change (%) 9% 3% 2% -26% -10% Value Change (%) 9% 3% 7% 9% 101% Value ($) $356,726,920 $230,302,033 $35,418,709 $12,183,324 $4,958,281 Value ($) Volume (units) 338,441 193,273 1,339,607 1,113,107 1,162,149 Volume change (%) 8% 2% 1% -28% -10% Volume change (%) 9% 2% -3% 2% 88% Volume (units) 338,441 2,200,435 1,725,033 1,641,863 528,252 AMGEN LILLY ROCHE BRISTOLMYER SQUIBB THERAMEX AUSTRALIA PTY LTD CHLORAMPHENICOL + HYPROMELLOSE CHLORAMPHENICOL Top molecule growth YoY AFLIBERCEPT RANIBIZUMAB LATANOPROST CHLORAMPHENICOL + HYPROMELLOSE CHLORAMPHENICOL Ranked by value of change AFLIBERCEPT RANIBIZUMAB DEXAMETHASONE TIMOLOL + TRAVOPROST CLIOQUINOL + FLUMETASONE Top 5 corporate % shares BAYER PHARMA NOVARTIS ALLERGAN UPJOHN MUNDIPHARMA NERVOUS SYSTEM Pharmacy Value Value Change Top 5 Molecules by Value FINGOLIMOD PREGABALIN CODEINE + PARACETAMOL NALOXONE + OXYCODONE ESCITALOPRAM Top molecule growth YoY FINGOLIMOD PREGABALIN CODEINE + PARACETAMOL NALOXONE + OXYCODONE ESCITALOPRAM Ranked by value of change CLADRIBINE GUANFACINE MELATONIN LISDEXAMFETAMINE TAPENTADOL $2,486,847,018 4% 105,272,932 3% Value ($) $124,221,421 $118,703,888 $94,652,180 $85,331,561 $70,680,747 Value Change (%) -6% -18% 1% -4% 12% Value Change (%) 71% 90% 30% 28% 23% Volume (units) 56,068 4,032,148 12,739,253 2,346,009 5,476,604 Volume change (%) -6% 2% -4% -5% 10% Volume change (%) 70% 90% 29% 29% 25% CONSUMER REPORT BABY FOODS Pharmacy Value Value Change Top 5 SKUs by Value $343,591,531 -25% Pharmacy Volume Volume Change 17,328,645 -26% Value ($) Volume (units) 1,579,840 801,202 580,625 A2 PLATINUM FORM STAGE 3 900 G APTAMIL PROFUTURA STAGE 3 POWDER 900 G A2 PLATINUM FORM STAGE 2 900 G $43,606,173 $23,316,617 $17,703,060 RETAIL PHARMACY • NOV/DEC 2020